Advertisement

Topics

GLOVCO Limited Company Profile

19:56 EST 17th November 2017 | BioPortfolio

Glovco (M) Sdn Bhd is a well established, MS ISO9002 accredited glove manufacturer, with production capacity of 50 to 60 million pieces gloves per month. Current turnover is RM38 million per annum. The Glovco Group has a total paid up capital of RM12.80 million.
Incorporated in 1988, production commenced in 1989. The Company progressed over the years with full commitment to quality in all aspects of our operation to the final product. Customers demand for further expansion saw our own factory developed on a 4.7 acres site operational in 1997 with 10 machines.

Continued Research & Development and exploitation of new technology has allowed the redefining of quality standards for our product upwards, and enhanced our competitiveness in the world market. The groundwork for quality was established from the beginning by the introduction of the Good Manufacturing Practice (GMP). In line with the GMP and its philosophy of "Quality without Compromise", a series of stringent testing and inspections are instituted throughout the production process, to ensure total quality control.

Location

PO Box 133
Bodfish
California
93205
United States of America

Contact

Fax: (212) 656-1047
Email: sales@theglove4theartist.com.


News Articles [18 Associated News Articles listed on BioPortfolio]

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

GLOVCO (Europe) Limited

GLOVCO manufactures new natural rubber latex examination gloves. New reduced protein and polymer coated natural rubber latex examination gloves should reduce concerns about latex allergy and glove pow...

GLOVCO Limited

Glovco (M) Sdn Bhd is a well established, MS ISO9002 accredited glove manufacturer, with production capacity of 50 to 60 million pieces gloves per month. Current turnover is RM38 million per annum. Th...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "GLOVCO Limited" on BioPortfolio

We have published hundreds of GLOVCO Limited news stories on BioPortfolio along with dozens of GLOVCO Limited Clinical Trials and PubMed Articles about GLOVCO Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLOVCO Limited Companies in our database. You can also find out about relevant GLOVCO Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record